Drug Profile
Zoledronic acid oral - Thar Pharmaceuticals
Alternative Names: T 121E01F; T121Latest Information Update: 20 Oct 2021
Price :
$50
*
At a glance
- Originator Thar Pharmaceuticals
- Class Antineoplastics; Bisphosphonates; Calcium regulators; Imidazoles; Osteoporosis therapies; Small molecules
- Mechanism of Action Bone resorption factor inhibitors; Geranyltranstransferase inhibitors; Osteoclast inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Complex regional pain syndromes
Most Recent Events
- 23 Dec 2019 No development reported - Phase-III for Complex regional pain syndromes in USA (PO)
- 26 Feb 2013 Oral zoledronic acid is available for licensing. www.tharpharma.com